<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00600678</url>
  </required_header>
  <id_info>
    <org_study_id>N-PRX-02-DE</org_study_id>
    <nct_id>NCT00600678</nct_id>
  </id_info>
  <brief_title>Gastric Emptying Study After Administration of a High Caloric Sip Feed</brief_title>
  <official_title>Characterisation of Gastric Emptying of a High Caloric Sip Feed Using the Paracetamol Absorption Method: Intraindividual Comparison of Paracetamol Pharmacokinetics After Oral co-Administration With Sip-Feed and After Intravenous Administration in Healthy Volunteers of Both Genders in an Open, Single Centre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresenius Kabi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measurement of gastric emptying time of an oral nutritional supplement (ProvideXtra DRINK) by
      using the paracetamol absorption method in healthy volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>- Gastric emptying after a single oral administration of a nutritional supplement</measure>
    <time_frame>Time frame gastric emptying: blood samples will be taken at predefined time points, up to 12h after application of test product.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety and tolerability</measure>
    <time_frame>entire study</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Enteral Nutrition</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ProvideXtra DRINK (oral nutritional supplement, food for special medical purposes)</intervention_name>
    <description>Single, oral administration of nutritional supplement under fasting condition within 2 minutes.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  caucasian origin

          -  BMI: 22kg/m2 - 27kg/m2;

        Exclusion Criteria:

          -  existing diseases and/or pathological findings, which might interfere with the safety,
             tolerability, absorption and/or pharmacokinetics of paracetamol (e.g. gastrointestinal
             or liver disease),

          -  known allergic reactions to investigational products,

          -  diseases and/or pathological findings, which could affect absorption, metabolism
             and/or gastric emptying (e.g. dyspepsia and gastroesophageal reflux),

          -  regular medication which can influence hepatic biotransformation and/or absorption,

          -  alcohol dependence, blood donation;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Donath, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SocraTec R&amp;D GmbH, Clinical Pharmacology Unit, Erfurt, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SocraTec R&amp;D GmbH, Clinical Pharmacology Unit</name>
      <address>
        <city>Erfurt</city>
        <state>Thueringen</state>
        <zip>99084</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2008</study_first_submitted>
  <study_first_submitted_qc>January 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2008</study_first_posted>
  <last_update_submitted>May 14, 2008</last_update_submitted>
  <last_update_submitted_qc>May 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2008</last_update_posted>
  <responsible_party>
    <name_title>Frank Folchert</name_title>
    <organization>Fresenius Kabi Deutschland GmbH</organization>
  </responsible_party>
  <keyword>food for special medical purposes</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

